Share This Video

Diabetes in America: The Beta Cell in Type 2 Diabetes

In this video, Dr. Leahy reviews the current understanding of beta-cell failure in type 2 diabetes.
Jack L. Leahy, MD
Professor of Medicine and Chief of Endocrinology, Diabetes, and Metabolism Unit
University of Vermont College of Medicine
Burlington, Vermont
Jack L. Leahy, MD

References:

  1. Bergenstal RM, Kendal DM, Franz MJ, Rubenstein AH. Management of type II diabetes: a systematic approach to meeting the standards of care. II: oral agents, insulin, and management of complications. In: De Groot LJ, Jameson JL, eds. Endocrinology. 4th ed. Philadelphia, PA: WB Saunders; 2001.
  2. Lebovitz HE. Insulin secretagogues: old and new. Diabetes Rev. 1999;7(3):139-153.
  3. Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA. ß-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab. 2005;90(1):493-500.
  4. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52(1):102-110.
  5. Leahy JL. Pathogenesis of type 2 diabetes mellitus. Arch Med Res. 2005;36(3):197-209.
  6. Wajchenberg BL. Beta-cell failure in diabetes and preservation by clinical treatment. Endocr Rev. 2007;28(2):187-218.
  7. Donath MY, Ehses JA, Maedler K, et al. Mechanisms of ß-cell death in type II diabetes. Diabetes. 2005;54(suppl 2):S108-S113.
  8. Donath MY, Gross DJ, Cerasi E, Kaiser N. Hyperglycemia-induced ß-cell apoptosis in pancreatic islets of Psammomys obersus during development of diabetes. Diabetes. 1999;48(4):738-744.
  9. Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 1993;42(11):1663-1672.